PWR
76
-2
CF
29
2
GWW
51
-4
MCK
69
3
ILMN
26
-4
CMS
67
2
TROW
56
-2
SYY
56
2
MDLZ
55
7
NTRS
47
-2
SWKS
42
2
ACN
42
4
NAVI
40
-3
MKC
50
2
V
72
4
CI
62
12
ETR
66
3
AN
58
-3
CA
44
4
C
47
-3
PWR
76
-2
CF
29
2
GWW
51
-4
MCK
69
3
ILMN
26
-4
CMS
67
2
TROW
56
-2
SYY
56
2
MDLZ
55
7
NTRS
47
-2
SWKS
42
2
ACN
42
4
NAVI
40
-3
MKC
50
2
V
72
4
CI
62
12
ETR
66
3
AN
58
-3
CA
44
4
C
47
-3
Financhill
Back

Pliant Therapeutics 10K Form

Buy
70

PLRX
Pliant Therapeutics

Last Price:
13.78
Seasonality Move:
78.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $1.58M
Cash Flow: $-31.76M
Price / Cash Flow: 0
Annual Sales: $7.25
Price / Book: 1.91

Profitability

EPS (TTM): -2.87000
Net Income (TTM): $-170.74M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pliant Therapeutics Earnings Forecast

Key Pliant Therapeutics Financial Ratios

  • The Research & Development expenses have been 8,088.42% of Revenue.
  • The Interest Expense is -0.79% of Operating Income.
  • The Net Earning history of PLRX is -10,211.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Pliant Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Buy
70
Pliant Therapeutics (PLRX) is a Buy

Is Pliant Therapeutics a Buy or a Sell?